China Market Intelligence

July 12th, 2017
By USCBC Staff

In response to member company concerns about the regulatory interpretation of recent laws and regulations over the past six months, the US-China Business Council (USCBC) continues its advocacy initiatives and its operating environment analyses and best practices for member companies in the United States and China. Policies enacting the Cybersecurity Law, developments in healthcare reform, and updates to the Anti-Unfair Competition Law have spurred USCBC formal comment letters to...

June 29th, 2017
By Lincoln Lin

A series of recent hospital reforms by the Chinese government are designed to standardize pricing and encourage investment in the medical system. Moves from medical and registration fees to a medical service fee and a new focus on establishing a system of family doctors could bring China’s public hospitals in line with many private hospitals and standard international practices.

Public hospitals have long been reliant on drug price markups and over-prescription to...

June 14th, 2017
By David Solomon

Four new policies under development may address a variety of lingering regulatory hurdles for foreign drug and device companies in China. The policies, issued in draft form for comment last month by the China Food and Drug Administration (CFDA), are a step toward improving nationwide access to high-quality drugs and devices, and are part of CFDA’s broader efforts to reform and modernize the Chinese healthcare sector during the 13th Five-Year Plan period.

The...

May 3rd, 2017
By David Solomon

As China aims to expand nationwide health insurance, improve patient access to care, strengthen primary care, and deepen investment in rural regions, US companies want in on the healthcare sector. In particular, medical devices — prominently featured in China’s strategic emerging industries campaign — provide opportunities for US companies, from burgeoning local innovation to changes in the distribution chain...

June 8th, 2016
Zoe Sophos

During the eighth Strategic & Economic Dialogue which concluded early this week in Beijing — the final round for the Obama administration, China said it would offer a revised Bilateral Investment Treaty (BIT) negative list next week in Washington, DC, according to statements made by Vice Premier Wang Yang and Treasury Secretary Jacob Lew.

The S&ED — the widest-ranging dialogue on the bilateral calendar — consists of two separate tracks covering economic and strategic topics in...

May 25th, 2016
David Solomon

Healthcare reform and a desire for universal healthcare are key components of the 13th Five-Year Plan and require commercial industry investment. China acknowledged these goals are dependent on efficient evaluation and approval procedures for medical devices and pharmaceuticals, improved research and development (R&D) of new medicines, and a successful, advanced online system for healthcare management and...